Artificial Organs · 2000 · 57 citations · 14 references
MedicineSurgeryProstheticsTissue EngineeringVascular SurgeryBiocompatibility Of Prosthetic MaterialsImplant Prosthetic MaterialsMaterial Selection For ProsthesesPolymeric BiomaterialsProsthetic FabricationProsthetic MaterialsImplant FabricationPolymer ImplantsPolymer ProsthesesPolymer Prosthetic MaterialsPolymeric Implant MaterialsPolymeric ImplantsPreliminary Investigation
The purpose of this study was to prepare a small diameter vascular prosthesis functioning without pseudointima formation. A nonthrombogenic phospholipid polymer, the 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer, has a cell membrane-like structure and has demonstrated strong nonthrombogenicity. We have recently prepared 2 kinds of vascular prostheses, 2 mm in diameter, composed of the MPC polymer and segmented polyurethane (SPU). One includes 7.5 wt% MPC polymer (SPU/MPC[7.5] prosthesis), and the other includes 10.0 wt% (SPU/MPC[10] prosthesis). These prostheses were placed in rabbit carotid arteries and were retrieved at 1 and 4 weeks after implantation. A pseudointima was observed at 4 weeks on the SPU/MPC(7.5). For the SPU/MPC(10), the surface was macroscopically clear without a pseudointima even after a 4 week implantation. It appears that the SPU/MPC(10) prosthesis, functioning without a pseudointima, possesses a stronger nonthrombogenicity and would be more applicable for clinical use.
14